Alnylam Pharmaceuticals
ALNY
#564
Rank
HK$345.39 B
Marketcap
HK$2,604
Share price
0.51%
Change (1 day)
35.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of December 2025 : HK$6.17 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has HK$6.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$HK$6.14 B1078.93%
2024-12-31$HK$0.52 B-130.22%
2023-12-31$-HK$1.73 Billion39.39%
2022-12-31$-HK$1.24 Billion-126.95%
2021-12-31$HK$4.58 B-41.78%
2020-12-31$HK$7.87 B-29.69%
2019-12-31$HK$11.20 B9.9%
2018-12-31$HK$10.19 B-26.12%
2017-12-31$HK$13.80 B93.4%
2016-12-31$HK$7.13 B-27.2%
2015-12-31$HK$9.80 B34.98%
2014-12-31$HK$7.26 B246.42%
2013-12-31$HK$2.09 B101.75%
2012-12-31$HK$1.03 B13.38%
2011-12-31$HK$0.91 B-25.57%
2010-12-31$HK$1.23 B-10.76%
2009-12-31$HK$1.37 B-11.65%
2008-12-31$HK$1.56 B0.58%
2007-12-31$HK$1.55 B-0.75%
2006-12-31$HK$1.56 B226.65%
2005-12-31$HK$0.47 B33.58%
2004-12-31$HK$0.35 B-273.22%
2003-12-31$-HK$0.21 Billion471.35%
2002-12-31$-HK$36.24 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
HK$364.13 B 5,798.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$675.07 B 10,835.10%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
HK$244.51 B 3,860.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$10.32 B 67.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$0.53 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$10.21 B 65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$61.90 B 902.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
HK$4.40 B-28.70%๐Ÿ‡บ๐Ÿ‡ธ USA